UNIVERSITY OF CINCINNATI
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1819-01-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- https://www.uc.edu/
AM-101 Enhances Radiation Therapy Efficacy in Lung Cancer with Brain Metastasis
Researchers have discovered that AM-101, a synthetic benzodiazepine analog, can enhance the efficacy of radiation therapy for lung cancer that has metastasized to the brain.
Progesterone Drug Provera Linked to Vision Loss in Meningioma Patients
A recent study identifies progesterone, specifically Provera, as a significant risk factor for vision loss related to meningiomas in premenopausal women.
Alzheimer's Drugs May Work by Boosting Healthy Amyloid Beta Protein, Study Suggests
• New research suggests Alzheimer's drugs like lecanemab and donanemab may slow disease progression by increasing levels of healthy amyloid beta (Aβ42) protein in the brain. • The study challenges the prevailing theory that these drugs work solely by reducing toxic amyloid plaques, highlighting the potential importance of soluble Aβ42 in maintaining brain health. • Researchers analyzed data from nearly 26,000 patients, finding that increased levels of soluble Aβ42 correlated with slower Alzheimer's progression during treatment with these monoclonal antibodies. • The study authors propose alternative therapies focused on boosting soluble Aβ42 levels directly, rather than solely targeting amyloid plaques, which may have long-term risks.